Table 2.
Cox proportional hazard regression analyses in relation to the composite outcome of death or cardiac hospitalization
| Variable | Planned Model* Hazard Ratio (95% CI) | P Value | Extended Model† Hazard Ratio (95% CI) | P Value |
|---|---|---|---|---|
| Etiology | 1.773 (1.151–2.730) | 0.009 | 2.167 (1.343–3.496) | 0.002 |
| LVEF | 0.973 (0.953–0.993) | 0.009 | 0.972 (0.953–0.992) | 0.006 |
| NT-ProBNP | 1.234 (1.114–1.368) | <0.0001 | 1.227 (1.107–1.360) | <0.0001 |
| Age | 0.914 (0.756–1.103) | 0.35 | 0.920 (0.764–1.107) | 0.38 |
| Baseline HR | 1.020 (1.000–1.039) | 0.047 | 1.020 (1.001–1.040) | 0.040 |
| Baseline Arterial Diameter | 1.232 (0.903–1.680) | 0.19 | 1.284 (0.931–1.171) | 0.13 |
| FMD | 1.046 (0.980–1.117) | 0.17 | 1.062 (0.993–1.135) | 0.08 |
| Hyperemic Flow | 0.923 (0.867–0.983) | 0.013 | 0.912 (0.854–0.973) | 0.0055 |
| Hyperlipidemia | - | - | 1.528 (0.963–2.426) | 0.07 |
Note: CI = confidence interval; LVEF = left ventricular ejection fraction; NT Pro-BNP = N-terminal pro-natriuretic peptide; HR = heart rate; FMD = flow-mediated dilation. NT-proBNP was expressed as NT-proBNP/1000, age was expressed as age/10 and hyperemic flow was expressed as hyperemic flow/1000.
Adjusted for etiology, LVEF, NT-ProBNP, age, baseline HR, baseline arterial diameter, hyperemic flow and FMD.
Adjusted for the variables in the a priori planned model, as well as hyperlipidemia